Clinics
Age and sex 89 years old female patient. Previous history no preleukemia no previous malignancy no inborn condition of note Organomegaly No hepatomegaly, splenomegaly (moderate), enlarged lymph nodes, no central nervous system involvement Blood WBC : 144 (lymphoma cells : 93%) Morphology showed small to medium sized lymphoid cells with pale cytoplasm and slightly to markedly irregular nuclear contour, sometimes mimicking centrocytes. Nucleoli were inconspicuous or absent.X 10 9 /l HB : 12.8g/dl Platelets : 196X 10 9 /l Blasts : NA Bone marrow : Bone marrow involvement (stage IV Ann Arbor). Note Rapid progression of the disease because 6 months ago laboratory analyses were normal (notably blood count).
Cyto-Pathology Classification
Phenotype: NA Immunophenotype lymphoma cells CD19+ CD5+ CD20+ (strong), CD22+ (strong), CD23+, FMC7+, monotypic kappa light-chain expression (moderate); Matutes score = 2/5. Rearranged Ig Tcr Not performed. Pathology Mantle cell lymphoma Electron microscopy Not performed. The t(2;12)(p12;p13), leading to the juxtaposition of the cyclin D2 CCND2 gene with the immunoglobulin kappa locus (IGK), defines a small subset of mantle cell lymphomas lacking cyclin D1 expression. Duployez N, et 
Other Molecular Studies
Technics: CCND1 (BCL1) expression evaluated by RT-PCR.
Results:
No CCND1 overexpression.
Partial GTG-banding karyotype of the t(2;12)(p12;p13).
FISH analysis of the t(2;12)(p12;p13)translocation, using painting probe of the short arm of chromosome 12 (WCP12p probe)in green. Arrows indicate the der(2) and der(12) chromosomes.
FISH analysis of the t(2;12) translocation, using BAC probe CCND2 RP11-264F23 in red and BAC probe RP11-530J6 located at 2q33 in green. Figure 3A is a normal metaphase and Figure 3B revealed the der(2) chromosome harboring CCND2 red signal.
The t(2;12)(p12;p13), leading to the juxtaposition of the cyclin D2 CCND2 gene with the immunoglobulin kappa locus (IGK), defines a small subset of mantle cell lymphomas lacking cyclin D1 expression. Duployez N, et al. Atlas Genet Cytogenet Oncol Haematol. 2016; 20 (3) 165
Leukemic phase of mantle cell lymphoma. Peripheral blood. Small to medium sized lymphoid cells with pale cytoplasm and slightly too markedly irregular nuclear contour, sometimes mimicking centrocytes. From a patient with 46,XX,t(2;12)(p12;p13).
Comments
According to the WHO classification of hematopoietic tumours, mantle cell lymphoma (MCL) is defined as a B-cell neoplasm composed of monomorphic small to medium-sized lymphoid cells with a CCND1 (cyclin D1) translocation. In recent years, it has been observed a small subset of lymphomas resembling conventional MCL both morphologically and phenotypically, with a similar gene expression profile but lacking the CCND1 translocation (Fu et al, Blood, 2005) . In 2013, Salaverria et al. investigated 40 welldefined CCDN1-negative MCL and identified 22 cases (55%) with CCND2 (cyclin D2) translocations (Salaverria et al, Blood, 2013) . Interestingly, it was noted that CCND2 predominantly translocates to IG light chain genes (15/22, 68%) in contrast with CCND1 translocations. Finally, in CCND1-negative MCL, the identification of CCND2 gene rearrangement provides a very robust marker for diagnosis.
